McCabe's Report
01/19/22 • 52 min
Coffee and Cardiology with Interventional Cardiologist Dr. Jamie McCabe to talk about what it takes to complete 150 mitraclip procedures, redefining how outcomes are measured, what leadership means to him and his crossroads between furniture making and medicine.
2:57 - Mitraclip
5:30 - Structural Heart Team
7:05 - Dynamics of multidisciplinary teams
9:40 - Volumes (Both sides)
16:40 - TAVR Returns
19:00 - TAVR Patient Selection
22:10 - Physician Report Cards
25:00 - Risk Treatment Paradox
29:40 - Leadership philosophy
33:45 - Vision of the Cath lab
37:23 - Impact of Covid
41:06 - Outside of the Lab
42:43 - The furniture maker?
49:08 - The pinnacle of structural heart
Dr. James (Jamie) McCabe grew up in Boston, Massachusetts, graduated magna cum laude from Bowdoin College and received his medical degree from Yale University. He has completed 10 years of post-medical school training including internal medicine training and general cardiology fellowship at University of California, San Francisco (UCSF) and interventional cardiology fellowship as well as an advanced interventional fellowship in structural and peripheral treatments at Brigham and Women's Hospital / Harvard Medical School. He is board certified in Internal Medicine, Cardiology, and Interventional Cardiology.
Dr. McCabe joined the University of Washington Medical Center in 2013. He became medical director of the Cardiac Cath Labs in 2015 and subsequently was named Chief of Interventional Cardiology for the UW System in 2020. His clinical practice leverages his knowledge and experience in clinical cardiovascular medicine and complex coronary and valvular heart interventions. Dr. McCabe is an international leader in structural heart interventions including repair or replacement of all heart valves using catheter-based methods. He also treats all forms of coronary artery blockage and cardiogenic shock. He is an internationally recognized clinician educator and investigator in transcatheter therapies for valvular heart disease. His research interests focus on quality and performance metrics for cardiovascular procedures and novel transcatheter therapies to address unmet needs in the structural heart space.
He has been the site principal investigator for dozens of clinical trials and has authored more than 100 original manuscripts and multiple book chapters related to his work. He lectures frequently at national and international meetings including at Transcatheter Cardiovascular Therapeutics (TCT), Trancatheter Valve Therapeutics (TVT), American College of Cardiology (ACC) and Society for Cardiac Angiography and Intervention (SCAI), amongst others. He has also been asked to perform live televised procedures for national and international audiences across multiple continents.
He has been recognized as an Emerging Leader in Medicine by SCAI and the ACC, named one of three finalists for the Linnemeier Award, and voted a “Top Doc” in cardiology multiple years in a row by Seattle Magazine and Seattle Met Magazine.
To reach Dr. Jamie McCabe you can email him at [email protected].
Or send a referral or consult request here: https://hipaa.jotform.com/uwheart/referrals
Coffee and Cardiology with Interventional Cardiologist Dr. Jamie McCabe to talk about what it takes to complete 150 mitraclip procedures, redefining how outcomes are measured, what leadership means to him and his crossroads between furniture making and medicine.
2:57 - Mitraclip
5:30 - Structural Heart Team
7:05 - Dynamics of multidisciplinary teams
9:40 - Volumes (Both sides)
16:40 - TAVR Returns
19:00 - TAVR Patient Selection
22:10 - Physician Report Cards
25:00 - Risk Treatment Paradox
29:40 - Leadership philosophy
33:45 - Vision of the Cath lab
37:23 - Impact of Covid
41:06 - Outside of the Lab
42:43 - The furniture maker?
49:08 - The pinnacle of structural heart
Dr. James (Jamie) McCabe grew up in Boston, Massachusetts, graduated magna cum laude from Bowdoin College and received his medical degree from Yale University. He has completed 10 years of post-medical school training including internal medicine training and general cardiology fellowship at University of California, San Francisco (UCSF) and interventional cardiology fellowship as well as an advanced interventional fellowship in structural and peripheral treatments at Brigham and Women's Hospital / Harvard Medical School. He is board certified in Internal Medicine, Cardiology, and Interventional Cardiology.
Dr. McCabe joined the University of Washington Medical Center in 2013. He became medical director of the Cardiac Cath Labs in 2015 and subsequently was named Chief of Interventional Cardiology for the UW System in 2020. His clinical practice leverages his knowledge and experience in clinical cardiovascular medicine and complex coronary and valvular heart interventions. Dr. McCabe is an international leader in structural heart interventions including repair or replacement of all heart valves using catheter-based methods. He also treats all forms of coronary artery blockage and cardiogenic shock. He is an internationally recognized clinician educator and investigator in transcatheter therapies for valvular heart disease. His research interests focus on quality and performance metrics for cardiovascular procedures and novel transcatheter therapies to address unmet needs in the structural heart space.
He has been the site principal investigator for dozens of clinical trials and has authored more than 100 original manuscripts and multiple book chapters related to his work. He lectures frequently at national and international meetings including at Transcatheter Cardiovascular Therapeutics (TCT), Trancatheter Valve Therapeutics (TVT), American College of Cardiology (ACC) and Society for Cardiac Angiography and Intervention (SCAI), amongst others. He has also been asked to perform live televised procedures for national and international audiences across multiple continents.
He has been recognized as an Emerging Leader in Medicine by SCAI and the ACC, named one of three finalists for the Linnemeier Award, and voted a “Top Doc” in cardiology multiple years in a row by Seattle Magazine and Seattle Met Magazine.
To reach Dr. Jamie McCabe you can email him at [email protected].
Or send a referral or consult request here: https://hipaa.jotform.com/uwheart/referrals
Previous Episode
Lombardi Unplugged
Coffee and Cardiology with Interventional Cardiologist Dr. Bill Lombardi to talk about FAME3, mental health and his passions for patient care.
Episode Markers:
1:40 TCT Live Cases - Why do them?3:30 Risk of CTO’s in Live Cases
6:21 Balancing Academics with Procedural Focus
8:50 What Bill learns from Teaching
11:05 Taking a break
13:55 Boundary setting
15:40 How to see the boundaries
16:27 FAME3
25:00 FAME3 Variables in Outcomes
27:21 Training the next generation
31:35 - Get in touch - [email protected] or email [email protected] for his direct contact information.
Dr. Bill Lombardi is a world-renowned expert in Complex Coronary Disease Therapies, performing over 500 interventions a year, including 250 CTOs.
He continues to develop novel chronic total occlusion (CTO) techniques and technologies, including the inception of a “hybrid algorithm” that facilitates successful, reproducible outcomes in CTO and complex lesion PCI. He has been involved with over 20 new technologies to improve PCI, including guide wires, micro-catheters, specialty balloons and novel approaches to reduce radiation and orthopedic injuries to operators.
He continues to innovate at the University of Washington Medical Center as clinical professor and Director of the Complex Coronary Disease Therapies Program.
Dr. Lombardi’s focus remains improving outcomes through numerous collaborations with his colleagues, industry, and teaching the next generation of CTO operators.
On his free time Dr. Lombardi enjoys spending time with his family on their boat “Lioness”, fishing, and exploring the outdoors.
Find Bill on Twitter @DrBillLombardi
To refer a patient complete this form https://hipaa.jotform.com/uwheart/referrals or reach out to [email protected]
Next Episode
Pal's Perspective
In this episode we welcome back Dr. Jay Pal our new Surgical Director of MCS and Transplant.
4:00 VAD's past & present
5:16 Patients & VAD
7:34 Future VADS
8:43 Artificial Heart
12:24 Surgery In's and Out's
14:35 Best Practices from Experience
17:00 Why Back to UW?
18:41 What's in the water at Duke?
20:10 Regional Partners
21:20 Partnering with Complexity in Care
24:16 Future of VADs
27:20 Thoughts on Allocation Changes
29:45 Nepal
37:32 Personal Benefits of Global Health
Jay Pal, MD, PhD is the Surgical Director of the Heart Transplantation and Mechanical Circulatory Support programs in the Division of Cardiothoracic Surgery. His clinical and research interests lie in the surgical treatment of heart failure, including transplantation and mechanical circulatory support systems.
He completed his general surgical residency at the UCSF Easy Bay program and his thoracic surgery residency at Duke University, where he developed an interest in heart failure. He has held faculty positions at the University of Texas Health Science Center San Antonio and the University of Colorado, as well as at the UW School of Medicine from 2013-2017.
In addition, Dr. Pal has been coordinating an international medical effort in Nepal for several years and will continue this work in collaboration with the Department of Global Health at the University of Washington.
He can be reached any time at [email protected]
or you can use our digital front door: https://hipaa.jotform.com/uwheart/referrals
Thanks for listening!
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/coffee-cardiology-214248/mccabes-report-24000338"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to mccabe's report on goodpods" style="width: 225px" /> </a>
Copy